Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment

BACKGROUND: SARS-CoV-2 has the Spike glycoprotein (S) which is crucial in attachment with host receptor and cell entry leading to COVID-19 infection. The current study was conducted to explore drugs against Receptor Binding Domain (RBD) of SARS-CoV-2 using in silico pharmacophore modelling and virtu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shehroz, Muhammad, Zaheer, Tahreem, Hussain, Tanveer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561340/
https://www.ncbi.nlm.nih.gov/pubmed/33083627
http://dx.doi.org/10.1016/j.heliyon.2020.e05278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561340/
https://www.ncbi.nlm.nih.gov/pubmed/33083627
http://dx.doi.org/10.1016/j.heliyon.2020.e05278

Ejemplares similares